Acute Intermittent Porphyria (AIP) is a rare genetic disorder caused by a deficiency in porphobilinogen deaminase, leading to an accumulation of neurotoxic porphyrin precursors. This results in severe neurovisceral attacks, significantly impacting patients' well-being. The Acute Intermittent Porphyria Market is growing due to enhanced awareness, improved diagnostics, and advancements in...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek